本页面由Tiger Trade Technology Pte. Ltd.提供服务

Agios Pharmaceuticals, Inc.

35.59
+0.49001.40%
盘后35.590.00000.00%16:10 EDT
成交量:74.44万
成交额:2,640.21万
市值:21.17亿
市盈率:-4.90
高:35.80
开:34.82
低:34.63
收:35.10
52周最高:46.00
52周最低:22.24
股本:5,947.16万
流通股本:5,061.86万
量比:0.53
换手率:1.47%
股息:- -
股息率:- -
每股收益(TTM):-7.2559
每股收益(LYR):-7.1203
净资产收益率:-32.82%
总资产收益率:-21.69%
市净率:1.91
市盈率(LYR):-5.00

数据加载中...

2026/06/19

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/06/18

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/07

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/29

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/29

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/29

重要事件披露

Form 8-K - Current report
2026/04/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/12

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]